NEWSROOM

Servier obtains Top Employer Europe 2021 certification

25 / 01 / 2021Press release

Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases

21 / 01 / 2021Press release

Financial Year 2019/2020 – Financial results and R&D strategy and pipeline

19 / 01 / 2021Press release

Servier appoints Pascal Lemaire as Executive Vice President Finance

07 / 01 / 2021Press release

Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases

06 / 01 / 2021Press release

Servier to Acquire Agios Pharmaceuticals’ Oncology Business

21 / 12 / 2020Press release

Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer

21 / 12 / 2020Press release

The Servier Group opens a worldwide Artificial Intelligence Hub in Montreal, in partnership with Centech

14 / 12 / 2020Press release

The French bioproduction sector announces the creation of Campus Biotech Digital, a platform unique in the world for bioproduction training

14 / 12 / 2020Press release

Servier launches its first oncology treatment in the solid tumor field in Brazil

08 / 12 / 2020Press release

Skolkovo and Servier support Russian startups in the field of oncology and autoimmune diseases

19 / 11 / 2020Press release

Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients

15 / 10 / 2020Press release